Breast Cancer Clinical Trials in Dallas, TX

Breast Cancer Clinical Trials in Dallas, TX

View the best 10 breast cancer medical studies in Dallas, Texas. Access promising new therapies by applying to a Dallas-based Breast Cancer clinical trial.

Trials in Dallas, Texas

Here are the top 10 medical studies for breast cancer in Dallas, Texas

Image of University of California Los Angeles Medical Center in Los Angeles, United States.

PRO1184

Chemotherapy

Recruiting1 awardPhase 1 & 2
This trial will test the safety, side effects and effectiveness of a new drug (PRO1184) to treat solid tumor cancers.
Image of Massachusetts General Hospital in Boston, United States.

IMM2902

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial tests IMM2902, a special protein that targets and helps destroy cancer cells with high levels of HER2, in patients with advanced solid tumors.
Image of University of Colorado in Aurora, United States.

CAB-ROR2-ADC

Antibody-drug conjugate

Recruiting1 awardPhase 1 & 2
This trial is testing a new targeted cancer treatment called CAB-ROR2-ADC in patients with advanced solid tumors. The drug seeks out cancer cells with a specific marker and delivers a potent treatment directly to them.
Image of Southern Cancer Center, PC ( Site 8003) in Daphne, United States.

Pembrolizumab +4 More

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing whether the cancer drug pembrolizumab is more effective than placebo when given with standard neoadjuvant and adjuvant therapy for high-risk early-stage ER+/HER2- breast cancer. The primary objectives are to compare pembrolizumab to placebo in terms of pathological complete response rate and event-free survival.
Image of Cedars Sinai Medical Center in Los Angeles, United States.

Pembrolizumab +3 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial is testing whether adding the drug pembrolizumab to a standard treatment regimen for HER2-positive breast cancer improves outcomes.
Image of St. Joseph's Hospital and Medical Center in Phoenix, United States.

Abemaciclib +1 More

CDK4/6 Inhibitor

Recruiting1 awardPhase 3
This trial is testing a combination of two drugs, abemaciclib and fulvestrant, for treating a specific type of breast cancer that has not responded to previous treatments. Abemaciclib is taken orally and is approved for treating certain types of breast cancer. The goal is to see if this combination can help stop the cancer from growing. The study may last several years, depending on how well the treatment works for each patient.
Image of HealthONE in Denver, United States.

RLY-2608 +1 More

PI3K Inhibitor

Recruiting1 awardPhase 1
This trial is designed to study the maximum tolerated dose, safety, and preliminary anti-cancer activity of RLY-2608 in patients with advanced solid tumors who have a PIK3CA mutation. The trial will have two parts: a dose escalation (Part 1) and a dose expansion (Part 2).
Image of Investigational Site Number 8400005 in Denver, United States.

Palbociclib

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug, amcenestrant, to see if it is safe and effective for treating breast cancer. The trial will test different doses of amcenestrant to find the maximum tolerated dose (MTD), and will also test amcenestrant in combination with other drugs to see if it is safe and effective.
Image of NEXT Oncology, Dallas in Dallas, United States.

NM1F Injection +1 More

Immunotherapy

Recruiting1 awardPhase 1
This trial tests a new drug to treat advanced cancer. It looks at safety, effectiveness, how it works in the body, and how it works with another drug.
Image of University of Alabama at Birmingham in Birmingham, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial is testing a new cancer treatment involving two drugs. It will study the side effects and if the drugs are effective in treating triple-negative breast cancer.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.